COVID-19 survivors have a 66% higher risk of developing type 1 or type 2 diabetes following their diagnosis compared to those who were not infected with the coronavirus, according to a study by Penn State College of Medicine researchers published Monday. The researchers found that SARS-CoV-2 — the virus that causes COVID-19 — binds to an enzyme receptor found on the surface of many organs and tissues, including cells found in the pancreas, small intestine, and kidneys, affecting insulin levels. Read more.

The post A Penn State Study Finds that COVID-19 Increases Diabetes Risk By 66% appeared first on Pennsylvania Office of Rural Health.